PMC:7095246 / 112-2374
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 561-565 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
T2 | 2184-2189 | Body_part | denotes | chest | http://purl.org/sig/ont/fma/fma9576 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 561-565 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
T2 | 602-606 | Body_part | denotes | lobe | http://purl.obolibrary.org/obo/UBERON_3010752 |
T3 | 764-768 | Body_part | denotes | lobe | http://purl.obolibrary.org/obo/UBERON_3010752 |
T4 | 2184-2189 | Body_part | denotes | chest | http://purl.obolibrary.org/obo/UBERON_0001443 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T2 | 105-113 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T3 | 190-198 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 727-730 | Disease | denotes | TSS | http://purl.obolibrary.org/obo/MONDO_0001881 |
T5 | 829-832 | Disease | denotes | TSS | http://purl.obolibrary.org/obo/MONDO_0001881 |
T6 | 926-929 | Disease | denotes | TSS | http://purl.obolibrary.org/obo/MONDO_0001881 |
T7 | 1132-1135 | Disease | denotes | TSS | http://purl.obolibrary.org/obo/MONDO_0001881 |
T8 | 1225-1228 | Disease | denotes | ICC | http://purl.obolibrary.org/obo/MONDO_0003210 |
T9 | 1342-1345 | Disease | denotes | TSS | http://purl.obolibrary.org/obo/MONDO_0001881 |
T10 | 1397-1400 | Disease | denotes | TSS | http://purl.obolibrary.org/obo/MONDO_0001881 |
T11 | 1523-1531 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T12 | 1709-1717 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T13 | 1789-1792 | Disease | denotes | ICC | http://purl.obolibrary.org/obo/MONDO_0003210 |
T14 | 1841-1844 | Disease | denotes | TSS | http://purl.obolibrary.org/obo/MONDO_0001881 |
T15 | 1986-1989 | Disease | denotes | TSS | http://purl.obolibrary.org/obo/MONDO_0001881 |
T16 | 2062-2065 | Disease | denotes | TSS | http://purl.obolibrary.org/obo/MONDO_0001881 |
T17 | 2154-2162 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-10 | http://purl.obolibrary.org/obo/BFO_0000030 | denotes | Objectives |
T2 | 137-138 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T3 | 209-211 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
T4 | 561-565 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T5 | 561-565 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
T6 | 896-900 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
T7 | 1001-1006 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | males |
T8 | 1001-1006 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | males |
T9 | 1014-1021 | http://purl.obolibrary.org/obo/UBERON_0003100 | denotes | females |
T10 | 1641-1644 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T11 | 1767-1770 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T12 | 2184-2189 | http://www.ebi.ac.uk/efo/EFO_0000965 | denotes | chest |
T13 | 2233-2234 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 1160-1165 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T2 | 1869-1874 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 0-10 | Sentence | denotes | Objectives |
T4 | 11-114 | Sentence | denotes | To explore the relationship between the imaging manifestations and clinical classification of COVID-19. |
T5 | 116-123 | Sentence | denotes | Methods |
T6 | 124-208 | Sentence | denotes | We conducted a retrospective single-center study on patients with COVID-19 from Jan. |
T7 | 209-225 | Sentence | denotes | 18, 2020 to Feb. |
T8 | 226-251 | Sentence | denotes | 7, 2020 in Zhuhai, China. |
T9 | 252-492 | Sentence | denotes | Patients were divided into 3 types based on Chinese guideline: mild (patients with minimal symptoms and negative CT findings), common, and severe-critical (patients with positive CT findings and different extent of clinical manifestations). |
T10 | 493-700 | Sentence | denotes | CT visual quantitative evaluation was based on summing up the acute lung inflammatory lesions involving each lobe, which was scored as 0 (0%), 1 (1–25%), 2 (26–50%), 3 (51–75%), or 4 (76–100%), respectively. |
T11 | 701-776 | Sentence | denotes | The total severity score (TSS) was reached by summing the five lobe scores. |
T12 | 777-824 | Sentence | denotes | The consistency of two observers was evaluated. |
T13 | 825-879 | Sentence | denotes | The TSS was compared with the clinical classification. |
T14 | 880-955 | Sentence | denotes | ROC was used to test the diagnosis ability of TSS for severe-critical type. |
T15 | 957-964 | Sentence | denotes | Results |
T16 | 965-1022 | Sentence | denotes | This study included 78 patients, 38 males and 40 females. |
T17 | 1023-1120 | Sentence | denotes | There were 24 mild (30.8%), 46 common (59.0%), and 8 severe-critical (10.2%) cases, respectively. |
T18 | 1121-1220 | Sentence | denotes | The median TSS of severe-critical-type group was significantly higher than common type (p < 0.001). |
T19 | 1221-1287 | Sentence | denotes | The ICC value of the two observers was 0.976 (95% CI 0.962–0.985). |
T20 | 1288-1392 | Sentence | denotes | ROC analysis showed the area under the curve (AUC) of TSS for diagnosing severe-critical type was 0.918. |
T21 | 1393-1458 | Sentence | denotes | The TSS cutoff of 7.5 had 82.6% sensitivity and 100% specificity. |
T22 | 1460-1471 | Sentence | denotes | Conclusions |
T23 | 1472-1604 | Sentence | denotes | The proportion of clinical mild-type patients with COVID-19 was relatively high; CT was not suitable for independent screening tool. |
T24 | 1605-1718 | Sentence | denotes | The CT visual quantitative analysis has high consistency and can reflect the clinical classification of COVID-19. |
T25 | 1720-1730 | Sentence | denotes | Key Points |
T26 | 1731-1829 | Sentence | denotes | • CT visual quantitative evaluation has high consistency (ICC value of 0.976) among the observers. |
T27 | 1830-1929 | Sentence | denotes | The median TSS of severe-critical type group was significantly higher than common type (p < 0.001). |
T28 | 1930-2057 | Sentence | denotes | • ROC analysis showed the area under the curve (AUC) of TSS for diagnosing severe-critical type was 0.918 (95% CI 0.843–0.994). |
T29 | 2058-2123 | Sentence | denotes | The TSS cutoff of 7.5 had 82.6% sensitivity and 100% specificity. |
T30 | 2124-2262 | Sentence | denotes | • The proportion of confirmed COVID-19 patients with normal chest CT was relatively high (30.8%); CT was not a suitable screening modality |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
5 | 105-113 | Disease | denotes | COVID-19 | MESH:C000657245 |
11 | 176-184 | Species | denotes | patients | Tax:9606 |
12 | 252-260 | Species | denotes | Patients | Tax:9606 |
13 | 321-329 | Species | denotes | patients | Tax:9606 |
14 | 408-416 | Species | denotes | patients | Tax:9606 |
15 | 190-198 | Disease | denotes | COVID-19 | MESH:C000657245 |
17 | 988-996 | Species | denotes | patients | Tax:9606 |
21 | 1509-1517 | Species | denotes | patients | Tax:9606 |
22 | 1523-1531 | Disease | denotes | COVID-19 | MESH:C000657245 |
23 | 1709-1717 | Disease | denotes | COVID-19 | MESH:C000657245 |
26 | 2163-2171 | Species | denotes | patients | Tax:9606 |
27 | 2154-2162 | Disease | denotes | COVID-19 | MESH:C000657245 |